neoplasm of the pituitary gland

Categories:

SOP Numbers	Date of Commencement	Incorporated Material	Status
Reasonable Hypothesis	Date of Commencement	Incorporated Material	Status
53/2015	18/09/2017	Guide to Calculation of Cumulative Equivalent Dose ARPANSA 2 August 2017	Current	Compilation

SOP Numbers	Date of Commencement	Incorporated Material	Status
Balance of Probabilities	Date of Commencement	Incorporated Material	Status
54/2015 54/2015	30/03/2015		Current	Principal

Subject	Documents	Relevant SOPs	Date	Comment
Amendment Explanatory Statements tabled in Houses of Parliament	Amendment Determination Explanatory Statement No 58 of 2017 Veterans Entitlements SOPs Cumulative Equivalent Dose 18 September 2017	58/2017	18/09/2017
RMA Investigation	RMA Declaration neoplasm of the pituitary gland RMA Declaration neoplasm of the pituitary gland	43/2004 46/2010	21/10/2011	Amendment SOP No. 122/2011 determined. No change to SOP No. 46/2010
Reference List	Reference list - neoplasm of the pituitary gland - RMA meeting June 2017	58/2017	06/06/2017
Explanatory Statements tabled in Houses of Parliament	SoP Explanatory statement 053 of 2015 RH 277 neoplasm of the pituitary gland 30 March 2015 SoP Explanatory statement 054 of 2015 BoP 277 neoplasm of the pituitary gland 30 March 2015	53/2015 54/2015	30/03/2015
SMRC Declaration - (No. 13)	SMRC Declaration neoplasm of the pituitary gland SMRC Declaration neoplasm of the pituitary gland	42/2004	25/02/2010	Amendment SOP No. 46/2010 determined as per SMRC direction